Kronos Bio, Inc.

NASDAQ:KRON

0.98 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 2.372.6882.522.2860.9171.8641.2210000000000000000
Cost of Revenue 00.421.2720.4780.511.1791.1541.1431.1541.141.0911.1630.8981.1150.90500000000
Gross Profit 2.372.2681.2481.8080.4070.6850.067-1.143-1.154-1.14-1.091-1.163-0.898-1.115-0.90500000000
Gross Profit Ratio 10.8440.4950.7910.4440.3670.0550000000000000000
Reseach & Development Expenses 12.26813.76513.74718.22625.34422.67319.65823.16823.40322.70624.43850.81924.68819.80217.59413.12516.7557.1756.1954.7483.5262.5862.586
General & Administrative Expenses 5.8186.3687.50610.9269.39811.35910.05610.51410.13510.82411.92711.5878.9859.3398.5847.9634.0541.6231.1541.1080.7970.6550.655
Selling & Marketing Expenses 00-0.7970000000000000000000.0780.078
SG&A 5.8186.3686.70910.9269.39811.35910.05610.51410.13510.82411.92711.5878.9859.3398.5847.9634.0541.6231.1541.1080.7970.7330.733
Other Expenses 00.57812.786000000000000-12.193-15.215000000
Operating Expenses 18.08620.71120.45629.15234.74234.03229.71433.68233.53833.5336.36562.40633.67329.14126.17821.08820.8098.7987.3495.8564.3233.3193.319
Operating Income -15.716-18.023-19.208-27.344-33.825-32.168-28.493-33.682-33.538-33.53-36.365-62.406-33.673-29.141-26.178-21.088-20.809-8.798-7.349-5.856-4.323-3.319-3.319
Operating Income Ratio -6.631-6.705-7.622-11.962-36.887-17.258-23.3360000000000000000
Total Other Income Expenses Net 1.6081.8232.0362.0242.4512.4272.2551.91.2820.6270.1020.0720.070.0860.092-12.069-18.9040.2190.3540.3910.31-0.001-0.001
Income Before Tax -14.108-16.2-29.958-25.32-31.374-29.741-26.238-31.782-32.256-32.903-36.263-62.334-33.603-29.055-26.086-33.157-39.713-8.579-6.995-5.465-4.013-3.32-3.32
Income Before Tax Ratio -5.953-6.027-11.888-11.076-34.214-15.955-21.4890000000000000000
Income Tax Expense 001.2293.334-0.510.457-2.824-2.629-1.282-0.627-0.102-0.4740.070.0860.092-12.493-11.3260.2190.355-0.3110.31100
Net Income -14.108-16.2-29.958-25.32-31.374-29.741-23.414-29.153-30.974-32.276-36.161-62.334-33.603-29.055-26.086-33.157-39.713-8.579-6.995-5.465-4.013-3.32-3.32
Net Income Ratio -5.953-6.027-11.888-11.076-34.214-15.955-19.1760000000000000000
EPS -0.23-0.27-0.5-0.43-0.54-0.52-0.41-0.52-0.55-0.58-0.65-1.13-0.61-0.53-0.48-0.7-0.73-0.17-0.25-0.19-0.14-0.69-0.69
EPS Diluted -0.23-0.27-0.5-0.43-0.54-0.52-0.41-0.52-0.55-0.58-0.65-1.13-0.61-0.53-0.48-0.7-0.73-0.17-0.25-0.19-0.14-0.69-0.69
EBITDA -15.304-17.025-18.733-24.842-33.315-28.562-27.924-33.108-32.967-32.966-35.808-61.171-33.15-28.677-25.734-30.824-34.65-8.615-6.766-5.715-3.859-3.256-3.256
EBITDA Ratio -6.457-6.334-7.117-11.752-36.887-16.947-23.3360000000000000000